These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34875507)
1. Comparing anti-aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease. Binyamin O; Frid K; Keller G; Saada A; Gabizon R Neurobiol Aging; 2022 Feb; 110():77-87. PubMed ID: 34875507 [TBL] [Abstract][Full Text] [Related]
2. Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD. Mizrahi M; Friedman-Levi Y; Larush L; Frid K; Binyamin O; Dori D; Fainstein N; Ovadia H; Ben-Hur T; Magdassi S; Gabizon R Nanomedicine; 2014 Aug; 10(6):1353-63. PubMed ID: 24704590 [TBL] [Abstract][Full Text] [Related]
3. Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administration. Frid K; Binyamin O; Usman A; Gabizon R Neurobiol Aging; 2020 Nov; 95():231-239. PubMed ID: 32861834 [TBL] [Abstract][Full Text] [Related]
5. Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice. Binyamin O; Nitzan K; Frid K; Ungar Y; Rosenmann H; Gabizon R Sci Rep; 2019 Dec; 9(1):18437. PubMed ID: 31804596 [TBL] [Abstract][Full Text] [Related]
6. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483 [TBL] [Abstract][Full Text] [Related]
7. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151 [TBL] [Abstract][Full Text] [Related]
8. Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice. Jaumain E; Quadrio I; Herzog L; Reine F; Rezaei H; Andréoletti O; Laude H; Perret-Liaudet A; Haïk S; Béringue V J Virol; 2016 Dec; 90(23):10867-10874. PubMed ID: 27681129 [TBL] [Abstract][Full Text] [Related]
10. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
11. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation. Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969 [TBL] [Abstract][Full Text] [Related]
12. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342 [TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene. Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment? Keller G; Binyamin O; Frid K; Saada A; Gabizon R Neurobiol Dis; 2019 Apr; 124():57-66. PubMed ID: 30423473 [TBL] [Abstract][Full Text] [Related]
15. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes. Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816 [TBL] [Abstract][Full Text] [Related]
16. A naturally occurring variant of the human prion protein completely prevents prion disease. Asante EA; Smidak M; Grimshaw A; Houghton R; Tomlinson A; Jeelani A; Jakubcova T; Hamdan S; Richard-Londt A; Linehan JM; Brandner S; Alpers M; Whitfield J; Mead S; Wadsworth JD; Collinge J Nature; 2015 Jun; 522(7557):478-81. PubMed ID: 26061765 [TBL] [Abstract][Full Text] [Related]
17. Genetic prion disease: no role for the immune system in disease pathogenesis? Friedman-Levi Y; Binyamin O; Frid K; Ovadia H; Gabizon R Hum Mol Genet; 2014 Aug; 23(15):4134-41. PubMed ID: 24667414 [TBL] [Abstract][Full Text] [Related]
18. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020 [TBL] [Abstract][Full Text] [Related]
19. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases. Moreno JA; Telling GC Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793 [TBL] [Abstract][Full Text] [Related]
20. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease. Sikorska B; Liberski PP Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]